Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale Director sold 5,539 shares at $40.00 ($221,560)
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 14,461 shares at an average $40.80 ($590,042)
  4. 4 Open-market sale Chief Executive Officer sold 36,149 shares at an average $40.47 ($1,462,808)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Director sold 11,650 shares at an average $36.83 ($429,085)
  10. 4 Open-market sale Director sold 38,107 shares at an average $36.96 ($1,408,612)
  11. 4 Open-market sale Chief Executive Officer sold 31,989 shares at an average $39.39 ($1,260,073)
  12. 4 Open-market sale Director sold 36,892 shares at an average $39.89 ($1,471,756)
  13. 4 Open-market sale Chief Executive Officer sold 108,999 shares at an average $40.91 ($4,459,330)
  14. 4 Open-market sale Director sold 38,351 shares at an average $38.19 ($1,464,793)
  15. 4 Open-market sale Chief Executive Officer sold 64,963 shares at an average $40.55 ($2,634,011)
  16. 4 Open-market sale Director sold 93,750 shares at $32.00 ($3,000,000)
  17. 4 Open-market buy Director bought 30,000 shares at $32.00 ($960,000)
  18. 4 Open-market buy Director bought 1,760,495 shares at $32.00 ($56,335,840)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 27 of 29 · 580 filings